MARINOMED BIOTECH AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.4 EUR | -0.80% |
|
-1.19% | -58.88% |
| 05-22 | Transcript : Marinomed Biotech AG, Q1 2024 Earnings Call, May 22, 2024 | |
| 05-21 | Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Marinomed Biotech AG
Price target over the last 5 years
History of analyst recommendation changes
b1.wST983H0HHDx2lgwpkOo7T4FeMd0S2EEsFmegYyNTQI.8kOfhS7ZagWzjApmkTnqpA1nFJcnEQVdiRjKrObkDF34VZa2G7V_P4axMw~c83062288d05c1b3f3e80fed18033ff5
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12.7
EUR
Average target price
63
EUR
Spread / Average Target
+396.06%
High Price Target
63
EUR
Spread / Highest target
+396.06%
Low Price Target
63
EUR
Spread / Lowest Target
+396.06%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- MARI Stock
- 93Z Stock
- Consensus Marinomed Biotech AG
